XML 76 R66.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information - Reportable Segment Information (Detail) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net sales:    
Net sales $ 2,465.0 $ 1,347.0
Segment Adjusted Operating EBITDA    
Operating profit 4.0 196.0
Other Depreciation and Amortization 242.0 81.0
Restructuring and other charges, net (4.0) (5.0)
Losses on sale of assets 0.0 (1.0)
Severance Costs (3.0) 0.0
Interest expense (65.0) (32.0)
Other income, net 7.0 (11.0)
Income before taxes (54.0) 153.0
Segment Adjusted Operating EBITDA 569.0 303.0
Shareholder Activism Related Costs (7.0) 0.0
Corporate and Other    
Segment Adjusted Operating EBITDA    
Restructuring and other charges, net (4.0) (5.0)
Losses on sale of assets 0.0 (1.0)
Compliance Review and Legal Defense Costs 0.0 (1.0)
Operating Segments | Nourish    
Net sales:    
Net sales 1,308.0 772.0
Segment Adjusted Operating EBITDA    
Segment Adjusted Operating EBITDA 270.0 176.0
Operating Segments | Scent    
Net sales:    
Net sales 569.0 541.0
Segment Adjusted Operating EBITDA    
Segment Adjusted Operating EBITDA 128.0 118.0
Operating Segments | Health & Biosciences    
Net sales:    
Net sales 426.0 34.0
Segment Adjusted Operating EBITDA    
Segment Adjusted Operating EBITDA 128.0 9.0
Operating Segments | Pharma Solutions    
Net sales:    
Net sales 162.0 0.0
Segment Adjusted Operating EBITDA    
Segment Adjusted Operating EBITDA 43.0 0.0
Nutrition & Biosciences, Inc    
Segment Adjusted Operating EBITDA    
Transaction related costs (89.0)  
Nutrition & Biosciences, Inc | Corporate and Other    
Segment Adjusted Operating EBITDA    
Integration-related costs (37.0) (10.0)
N&B Inventory Step-Up Costs (182.0) 0.0
Transaction related costs (89.0) (5.0)
Frutarom | Corporate and Other    
Segment Adjusted Operating EBITDA    
Integration-related costs $ (1.0) $ (4.0)